Novo Nordisk Signs $2.6 Billion Deal for Once-Weekly China-Developed Obesity Pill to Expand Weight-Loss Drug Portfolio
30 September 2026 Punjab Khabarnama Bureau : Novo Nordisk is strengthening its position in the rapidly expanding obesity treatment market through a deal worth up to $2.6 billion involving a…